Mergers Partnerships & Acquisitions

April 24, 2020

M&A

October 24, 2018
RNAi Therapeutics Come of Age: Exploring the Peaks & Troughs of Alnylam's Thirty Year Journey to First Approval

RNAi Therapeutics Come of Age: Exploring the Peaks & Troughs of Alnylam’s Thirty Year Journey to First Approval

August 10, 2018
Democratising DNA: 23andMe & GSK Collaboration Raises Privacy & Data Quality Concerns - Can Blockchain Offer a Disruptive Solution?

Democratising DNA: 23andMe & GSK Collaboration Highlights Data Quality & Privacy Concerns; Can Blockchain Offer a Disruptive Solution?

March 27, 2018

All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation

March 8, 2018
Charles River Laboratories M&A Activity Analysis: a Differentiated Strategy Delivering Results

Charles River Laboratories M&A Activity Analysis: A Differentiated Strategy Delivering Results

October 16, 2017
Evotec Invests €15m in Exscientia in Latest Partnership between Big Pharma & Artificial Intelligence

Evotec Invests €15m in Exscientia in Latest Partnership between Big Pharma & Artificial Intelligence-Driven Drug Discovery

August 31, 2017
The CAR-T Revolution: Gilead’s $12B Acquisition of Kite Pharma & FDA Approval of Novartis’ Kymriah Signal Tipping Point for Promising Cancer Immunotherapies

The CAR-T Revolution: Gilead’s $12B Acquisition of Kite Pharma & FDA Approval of Novartis’ Kymriah Signal Tipping Point for Promising Cancer Immunotherapies

May 23, 2017
Thermo Fisher Continues Vertical Integration with $7.2B Acquisition of CDMO Patheon

Thermo Fisher Continues Vertical Integration with $7.2B Acquisition of CDMO Patheon

April 12, 2017
GE Healthcare Adds to Its Cell Therapy Portfolio with Acquisition of Asymptote

GE Healthcare Adds to Its Cell Therapy Portfolio with Acquisition of Asymptote

Contact Us